Compounds > pyrazolanthrone
Page last updated: 2024-08-18

pyrazolanthrone and Cardiovascular Diseases

pyrazolanthrone has been researched along with Cardiovascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reddy, PA; Siddiqui, MA1
Damdindorj, L; Hosokawa, Y; Hossain, E; Karnan, S; Konishi, H; Konishi, Y; Ota, A; Takahashi, M1

Other Studies

2 other study(ies) available for pyrazolanthrone and Cardiovascular Diseases

ArticleYear
Small molecule JNK (c-Jun N-terminal kinase) inhibitors.
    Journal of medicinal chemistry, 2010, Apr-22, Volume: 53, Issue:8

    Topics: Allosteric Regulation; Animals; Cardiovascular Diseases; Crystallography, X-Ray; Humans; Inflammation; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Metabolic Diseases; Neurodegenerative Diseases; Protein Conformation; Protein Kinase Inhibitors; Signal Transduction

2010
Arsenic upregulates the expression of angiotensin II Type I receptor in mouse aortic endothelial cells.
    Toxicology letters, 2013, Jun-20, Volume: 220, Issue:1

    Topics: Acetylcysteine; Animals; Anthracenes; Aorta; Arsenites; Cardiovascular Diseases; Cell Line; Cell Proliferation; Endothelium, Vascular; Environmental Pollutants; Enzyme Inhibitors; Free Radical Scavengers; Mice; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Sodium Compounds; Up-Regulation

2013